{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T12:58:52Z","timestamp":1791896332344,"version":"4.3.4"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2004,2,1]],"date-time":"2004-02-01T00:00:00Z","timestamp":1075593600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intensive Care Med"],"published-print":{"date-parts":[[2004,2]]},"DOI":"10.1007\/s00134-003-2047-x","type":"journal-article","created":{"date-parts":[[2004,2,9]],"date-time":"2004-02-09T11:18:16Z","timestamp":1076325496000},"page":"260-265","source":"Crossref","is-referenced-by-count":287,"title":["Citrate vs. heparin for anticoagulation in continuous venovenous hemofiltration: a prospective randomized study"],"prefix":"10.1007","volume":"30","author":[{"given":"Mehran","family":"Monchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis","family":"Berghmans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didier","family":"Ledoux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Luc","family":"Canivet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Dubois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Damas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2004,2,1]]},"reference":[{"key":"2047_CR1","first-page":"S237","volume":"4","author":"Ward","year":"1993","unstructured":"Ward DM, Mehta RL (1993) Extracorporeal management of acute renal failure patients at high risk of bleeding. Kidney Int 4:S237\u2013S244","journal-title":"Kidney Int"},{"key":"2047_CR2","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.1097\/00003246-199910000-00026","volume":"27","author":"Reeves","year":"1999","unstructured":"Reeves JH, Cumming AR, Gallagher L, O\u2019Brien JL, Santamaria JD (1999) A controlled trial of low-molecular-weight heparin (dalteparin) versus unfractionated heparin as anticoagulant during continuous venovenous hemodialysis with filtration. Crit Care Med 27:2224\u20132228","journal-title":"Crit Care Med"},{"key":"2047_CR3","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1007\/s00134-002-1249-y","volume":"28","author":"Fiaccadori","year":"2002","unstructured":"Fiaccadori E, Maggiore U, Rotelli C, Minari M, Melfa L, Cappe G, Cabassi A (2002) Continuous haemofiltration in acute renal failure with prostacyclin as the sole anti-haemostatic agent. Intensive Care Med 28:586\u2013593","journal-title":"Intensive Care Med"},{"key":"2047_CR4","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1159\/000420222","volume":"93","author":"Ohtake","year":"1991","unstructured":"Ohtake Y, Hirasawa H, Sugai T, Oda S, Shiga H, Matsuda K, Kitamura N (1991) Nafamostat mesylate as anticoagulant in continuous hemofiltration and continuous hemodiafiltration. Contrib Nephrol 93:215\u2013217","journal-title":"Contrib Nephrol"},{"key":"2047_CR5","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1007\/s001340000691","volume":"26","author":"Tan","year":"2000","unstructured":"Tan HK, Baldwin I, Bellomo R (2000) Continuous veno-venous hemofiltration without anticoagulation in high-risk patients. Intensive Care Med 26:1652\u20131657","journal-title":"Intensive Care Med"},{"key":"2047_CR6","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1007\/s00134-003-1672-8","volume":"29","author":"Uchino","year":"2003","unstructured":"Uchino S, Fealy N, Baldwin I, Morimatsu H, Bellomo R (2003) Continuous is not continuous: the incidence and impact of circuit \u201cdown-time\u201d on uraemic control during continuous veno-venous haemofiltration. Intensive Care Med 29:575\u2013578","journal-title":"Intensive Care Med"},{"key":"2047_CR7","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1007\/s001340000676","volume":"26","author":"Cutts","year":"2000","unstructured":"Cutts MW, Thomas AN, Kishen R (2000) Transfusion requirements during continuous veno-venous haemofiltration: the importance of filter life. Intensive Care Med 26:1694\u20131697","journal-title":"Intensive Care Med"},{"key":"2047_CR8","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1046\/j.1523-1755.1999.00444.x","volume":"55","author":"Palsson","year":"1999","unstructured":"Palsson R, Niles JL (1999) Regional citrate anticoagulation in continuous venovenous hemofiltration in critically ill patients with a high risk of bleeding. Kidney Int 55:1991\u20131997","journal-title":"Kidney Int"},{"key":"2047_CR9","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/S0272-6386(00)70248-4","volume":"35","author":"Kutsogiannis","year":"2000","unstructured":"Kutsogiannis DJ, Mayers I, Chin WD, Gibney RT (2000) Regional citrate anticoagulation in continuous venovenous hemodiafiltration. Am J Kidney Dis 35:802\u2013811","journal-title":"Am J Kidney Dis"},{"key":"2047_CR10","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/S0140-6736(00)02430-2","volume":"356","author":"Ronco","year":"2000","unstructured":"Ronco C, Bellomo R, Homel P, Brendolan A, Dan M, Piccinni P, La Greca G (2000) Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomised trial. Lancet 356:26\u201330","journal-title":"Lancet"},{"key":"2047_CR11","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1038\/ki.1990.300","volume":"38","author":"Mehta","year":"1990","unstructured":"Mehta RL, McDonald BR, Aguilar MM, Ward DM (1990) Regional citrate anticoagulation for continuous arteriovenous hemodialysis in critically ill patients. Kidney Int 38:976\u2013981","journal-title":"Kidney Int"},{"key":"2047_CR12","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1007\/s00134-002-1443-y","volume":"28","author":"Gabutti","year":"2002","unstructured":"Gabutti L, Marone C, Colucci G, Duchini F, Schonholzer C (2002) Citrate anticoagulation in continuous venovenous hemodiafiltration: a metabolic challenge. Intensive Care Med 28:1419\u20131425","journal-title":"Intensive Care Med"},{"key":"2047_CR13","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1046\/j.1523-1755.2001.00809.x","volume":"60","author":"Tolwani","year":"2001","unstructured":"Tolwani AJ, Campbell RC, Schenk MB, Allon M, Warnock DG (2001) Simplified citrate anticoagulation for continuous renal replacement therapy. Kidney Int 60:370\u2013374","journal-title":"Kidney Int"},{"key":"2047_CR14","doi-asserted-by":"publisher","first-page":"2957","DOI":"10.1001\/jama.1993.03510240069035","volume":"270","author":"Le","year":"1993","unstructured":"Le Gall JR, Lemeshow S, Saulnier F (1993) A new Simplified Acute Physiology Score (SAPS II) based on a European\/North American multicenter study. JAMA 270:2957\u20132963","journal-title":"JAMA"},{"key":"2047_CR15","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1001\/jama.1996.03540100046027","volume":"276","author":"Le","year":"1996","unstructured":"Le Gall JR, Klar J, Lemeshow S, Saulnier F, Alberti C, Artigas A, Teres D (1996) The Logistic Organ Dysfunction system. A new way to assess organ dysfunction in the intensive care unit. ICU Scoring Group. JAMA 276:802\u2013810","journal-title":"JAMA"}],"container-title":["Intensive Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00134-003-2047-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00134-003-2047-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00134-003-2047-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00134-003-2047-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T08:49:29Z","timestamp":1558601369000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00134-003-2047-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,2]]},"references-count":15,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004,2]]}},"alternative-id":["2047"],"URL":"https:\/\/doi.org\/10.1007\/s00134-003-2047-x","relation":{},"ISSN":["0342-4642","1432-1238"],"issn-type":[{"value":"0342-4642","type":"print"},{"value":"1432-1238","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,2]]}}}